{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:43:18Z","timestamp":1792554198139,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"DOI":"10.1245\/s10434-026-20700-6","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:55:07Z","timestamp":1792508107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Extended-Duration Venous Thromboprophylaxis After Cancer Surgery"],"prefix":"10.1245","author":[{"given":"Xing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"issue":"1","key":"20700_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","volume":"8","author":"AA Khorana","year":"2022","unstructured":"Khorana AA, Mackman N, Falanga A, et al. Cancer-associated venous thromboembolism. Nat Rev Dis Primers. 2022;8(1):11. https:\/\/doi.org\/10.1038\/s41572-022-00336-y.","journal-title":"Nat Rev Dis Primers."},{"issue":"2","key":"20700_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1634\/theoncologist.2016-0214","volume":"22","author":"E Donnellan","year":"2017","unstructured":"Donnellan E, Khorana AA. Cancer and venous thromboembolic disease: a review. Oncologist. 2017;22(2):199\u2013207. https:\/\/doi.org\/10.1634\/theoncologist.2016-0214.","journal-title":"Oncologist."},{"issue":"15","key":"20700_CR3","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1182\/bloodadvances.2022009577","volume":"7","author":"MJT Crobach","year":"2023","unstructured":"Crobach MJT, Anijs RJS, Br\u00e6kkan SK, et al. Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study. Blood Adv. 2023;7(15):4072\u20139. https:\/\/doi.org\/10.1182\/bloodadvances.2022009577.","journal-title":"Blood Adv."},{"key":"20700_CR4","doi-asserted-by":"publisher","unstructured":"S\u00f8rensen HT, Pedersen L, van Es N, et al. Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study. The Lancet Regional Health - Europe. 2023;34 https:\/\/doi.org\/10.1016\/j.lanepe.2023.100739.","DOI":"10.1016\/j.lanepe.2023.100739"},{"issue":"16","key":"20700_CR5","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/jco.23.00294","volume":"41","author":"NS Key","year":"2023","unstructured":"Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update. J Clin Oncol. 2023;41(16):3063\u201371. https:\/\/doi.org\/10.1200\/jco.23.00294.","journal-title":"J Clin Oncol."},{"issue":"4","key":"20700_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","volume":"5","author":"GH Lyman","year":"2021","unstructured":"Lyman GH, Carrier M, Ay C, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021;5(4):927\u201374. https:\/\/doi.org\/10.1182\/bloodadvances.2020003442.","journal-title":"Blood Adv."},{"issue":"1","key":"20700_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jth.13563","volume":"15","author":"SJ van der Wall","year":"2017","unstructured":"van der Wall SJ, Klok FA, den Exter PL, et al. Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice. J Thromb Haemostasis. 2017;15(1):74\u20139. https:\/\/doi.org\/10.1111\/jth.13563.","journal-title":"J Thromb Haemostasis."},{"issue":"1","key":"20700_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/rth2.12002","volume":"1","author":"AA Khorana","year":"2017","unstructured":"Khorana AA, McCrae KR, Milentijevic D, et al. Current practice patterns and patient persistence with anticoagulant treatments for cancer-associated thrombosis. Res Pract Thromb Haemostasis. 2017;1(1):14\u201322. https:\/\/doi.org\/10.1002\/rth2.12002.","journal-title":"Res Pract Thromb Haemostasis."},{"issue":"4","key":"20700_CR9","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jtha.2025.01.002","volume":"23","author":"T Gyldenholm","year":"2025","unstructured":"Gyldenholm T, Madsen N, Katballe N, et al. Prolonged vs standard thromboprophylaxis in patients with esophageal cancer undergoing surgery: a randomized controlled study. J Thromb Haemostasis. 2025;23(4):1367\u201378. https:\/\/doi.org\/10.1016\/j.jtha.2025.01.002.","journal-title":"J Thromb Haemostasis."},{"key":"20700_CR10","doi-asserted-by":"publisher","unstructured":"Auer RC, Ott M, Karanicolas P, et al. Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial. BMJ. 2022;378 https:\/\/doi.org\/10.1136\/bmj-2022-071375.","DOI":"10.1136\/bmj-2022-071375"},{"issue":"04","key":"20700_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1055\/a-2628-3967","volume":"126","author":"G Maraziti","year":"2025","unstructured":"Maraziti G, Pititto GN, Squizzato A, et al. Direct oral anticoagulants for prevention of venous thromboembolism after cancer-related surgery: systematic review and network meta-analysis. Thromb Haemostasis. 2025;126(04):429\u201338. https:\/\/doi.org\/10.1055\/a-2628-3967.","journal-title":"Thromb Haemostasis."},{"issue":"4","key":"20700_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1182\/blood-2018-08-835595","volume":"133","author":"N Kraaijpoel","year":"2019","unstructured":"Kraaijpoel N, Carrier M. How I treat cancer-associated venous thromboembolism. Blood. 2019;133(4):291\u20138. https:\/\/doi.org\/10.1182\/blood-2018-08-835595.","journal-title":"Blood."},{"issue":"1","key":"20700_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","volume":"8","author":"S Schulman","year":"2010","unstructured":"Schulman S, Anger\u00c5S U, Bergqvist D, et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemostasis. 2010;8(1):202\u20134. https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03678.x.","journal-title":"J Thromb Haemostasis."},{"issue":"11","key":"20700_CR14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384. https:\/\/doi.org\/10.7326\/M14-2385.","journal-title":"Ann Intern Med."},{"key":"20700_CR15","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928.","journal-title":"BMJ."},{"issue":"4","key":"20700_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026.","journal-title":"J Clin Epidemiol."},{"issue":"8","key":"20700_CR17","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/ajh.26945","volume":"98","author":"M Zhao","year":"2023","unstructured":"Zhao M, Bao Y, Jiang C, et al. Rivaroxaban versus nadroparin for thromboprophylaxis following thoracic surgery for lung cancer: a randomized, noninferiority trial. Am J Hematol. 2023;98(8):1185\u201395. https:\/\/doi.org\/10.1002\/ajh.26945.","journal-title":"Am J Hematol."},{"key":"20700_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/10760296221132556","volume":"28","author":"ALM Longo de Oliveira","year":"2022","unstructured":"Longo de Oliveira ALM, de Oliveira Pereira RF, Agati LB, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after major gynecological cancer surgery: the VALERIA trial. Clin Appl Thromb Hemostasis. 2022;28:107. https:\/\/doi.org\/10.1177\/10760296221132556.","journal-title":"Clin Appl Thromb Hemostasis."},{"issue":"8","key":"20700_CR19","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1182\/blood.2022015796","volume":"140","author":"C Becattini","year":"2022","unstructured":"Becattini C, Pace U, Pirozzi F, et al. Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer. Blood. 2022;140(8):900\u20138. https:\/\/doi.org\/10.1182\/blood.2022015796.","journal-title":"Blood."},{"issue":"4","key":"20700_CR20","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1053\/j.semtcvs.2021.02.032","volume":"33","author":"Y Shargall","year":"2021","unstructured":"Shargall Y, Schneider L, Linkins L-A, et al. Double blind pilot randomized trial comparing extended anticoagulation to placebo following major lung resection for cancer. Sem Thorac Cardiovasc Surg. 2021;33(4):1123\u201334. https:\/\/doi.org\/10.1053\/j.semtcvs.2021.02.032.","journal-title":"Sem Thorac Cardiovasc Surg."},{"issue":"6","key":"20700_CR21","doi-asserted-by":"publisher","first-page":"e207410","DOI":"10.1001\/jamanetworkopen.2020.7410","volume":"3","author":"SR Guntupalli","year":"2020","unstructured":"Guntupalli SR, Brennecke A, Behbakht K, et al. Safety and efficacy of apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasm. JAMA Netw Open. 2020;3(6):e207410. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.7410.","journal-title":"JAMA Netw Open."},{"issue":"5","key":"20700_CR22","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.21873\/anticanres.13385","volume":"39","author":"Y Tanaka","year":"2019","unstructured":"Tanaka Y, Yamada A, Hirata S, et al. Efficacy and safety of enoxaparin for prophylaxis of postoperative venous thromboembolism after esophagectomy: a single-center prospective randomized controlled phase II study. Anticancer Res. 2019;39(5):2615\u201325. https:\/\/doi.org\/10.21873\/anticanres.13385.","journal-title":"Anticancer Res."},{"issue":"4","key":"20700_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/sla.0000000000000340","volume":"259","author":"MC Vedovati","year":"2014","unstructured":"Vedovati MC, Becattini C, Rondelli F, et al. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg. 2014;259(4):665\u20139. https:\/\/doi.org\/10.1097\/sla.0000000000000340.","journal-title":"Ann Surg."},{"issue":"3","key":"20700_CR24","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/j.thromres.2012.06.009","volume":"130","author":"M Sakon","year":"2012","unstructured":"Sakon M, Nakamura M. Darexaban (YM150) prevents venous thromboembolism in Japanese patients undergoing major abdominal surgery: Phase III randomized, mechanical prophylaxis-controlled, open-label study. Thromb Res. 2012;130(3):e52\u20139. https:\/\/doi.org\/10.1016\/j.thromres.2012.06.009.","journal-title":"Thromb Res."},{"issue":"3","key":"20700_CR25","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.thromres.2009.09.009","volume":"125","author":"M Sakon","year":"2010","unstructured":"Sakon M, Kobayashi T, Shimazui T. Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: results from a multicenter, randomized, open-label study. Thromb Res. 2010;125(3):e65-70. https:\/\/doi.org\/10.1016\/j.thromres.2009.09.009.","journal-title":"Thromb Res."},{"issue":"6","key":"20700_CR26","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/j.1538-7836.2010.03892.x","volume":"8","author":"VV Kakkar","year":"2010","unstructured":"Kakkar VV, Balibrea JL, Mart\u00cdNez-Gonz\u00c1Lez J, et al. Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study. J Thromb Haemostasis. 2010;8(6):1223\u20139. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03892.x.","journal-title":"J Thromb Haemostasis."},{"issue":"13","key":"20700_CR27","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa012385","volume":"346","author":"D Bergqvist","year":"2002","unstructured":"Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346(13):975\u201380. https:\/\/doi.org\/10.1056\/NEJMoa012385.","journal-title":"N Engl J Med."},{"issue":"1","key":"20700_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12959-026-00853-w","volume":"24","author":"S Aminimoghaddam","year":"2026","unstructured":"Aminimoghaddam S, Mohazzab A, Pourali R, et al. Safety and efficacy of apixaban versus enoxaparin in gynecologic cancer patients undergoing open surgery: an open-label randomized controlled trial. Thromb J. 2026;24(1):34. https:\/\/doi.org\/10.1186\/s12959-026-00853-w.","journal-title":"Thromb J."},{"key":"20700_CR29","doi-asserted-by":"publisher","first-page":"109500","DOI":"10.1016\/j.thromres.2025.109500","volume":"255","author":"Z Wang","year":"2025","unstructured":"Wang Z, Yu Z, Niu T. Prolonged duration of pharmacological thromboprophylaxis following oncologic surgery: A systematic review and meta-analysis of RCTs. Thrombosis Res. 2025;255:109500. https:\/\/doi.org\/10.1016\/j.thromres.2025.109500.","journal-title":"Thrombosis Res."},{"key":"20700_CR30","doi-asserted-by":"publisher","first-page":"1445485","DOI":"10.3389\/fonc.2025.1445485","volume":"15","author":"S Qin","year":"2025","unstructured":"Qin S, Guo S, Yao Y, et al. Comparison of efficacy and safety of thrombus prevention strategies after abdominal and pelvic cancer surgery: Bayesian network based meta-analysis. Front Oncol. 2025;15:1445485. https:\/\/doi.org\/10.3389\/fonc.2025.1445485.","journal-title":"Front Oncol."},{"issue":"12","key":"20700_CR31","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1002\/ajh.70090","volume":"100","author":"A Mahmoud","year":"2025","unstructured":"Mahmoud A, Eltaher B, Shah P, et al. Reduced-dose versus full-dose direct oral anticoagulants for extended secondary venous thromboembolism prophylaxis in cancer patients: a systematic review and meta-analysis of randomized trials. Am J Hematol. 2025;100(12):2276\u201385. https:\/\/doi.org\/10.1002\/ajh.70090.","journal-title":"Am J Hematol."},{"issue":"6","key":"20700_CR32","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s10557-024-07620-x","volume":"39","author":"M-C Lee","year":"2024","unstructured":"Lee M-C, Wu J-Y, Yu T, et al. Clinical efficacy and safety of novel anticoagulants for the management of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. Cardiovasc Drugs Ther. 2024;39(6):1405\u201316. https:\/\/doi.org\/10.1007\/s10557-024-07620-x.","journal-title":"Cardiovasc Drugs Ther."},{"key":"20700_CR33","doi-asserted-by":"publisher","first-page":"109294","DOI":"10.1016\/j.thromres.2025.109294","volume":"249","author":"K Liu","year":"2025","unstructured":"Liu K, Hu C, Zhou L-y, et al. The efficacy and safety of low-molecular-weight heparins for venous thromboembolism prophylaxis in abdominal or pelvic cancer surgery: A systematic review and network meta-analysis of randomized controlled trials. Thromb Res. 2025;249:109294. https:\/\/doi.org\/10.1016\/j.thromres.2025.109294.","journal-title":"Thromb Res."},{"key":"20700_CR34","doi-asserted-by":"crossref","unstructured":"Model Fit, Model Comparison and Outlier Detection. Network Meta\u2010Analysis for Decision Making. 2018:59-91.","DOI":"10.1002\/9781118951651.ch3"},{"issue":"2","key":"20700_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jaccao.2021.03.001","volume":"3","author":"L Gervaso","year":"2021","unstructured":"Gervaso L, Dave H, Khorana AA. Venous and arterial thromboembolism in patients with cancer. JACC CardioOncology. 2021;3(2):173\u201390. https:\/\/doi.org\/10.1016\/j.jaccao.2021.03.001.","journal-title":"JACC CardioOncology."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20700-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:25:32Z","timestamp":1792553132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20700-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":35,"alternative-id":["20700"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20700-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Ethics"}}]}}